Related Experiment Video
Updated: Jan 10, 2026
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
Pediatric T-Lymphoblastic Leukemia With Aberrant B-Cell Marker Expression: A Potential Role for Targeted Therapy
Mahsa Khanlari1, Wei Wang2, Paul E Mead1
1Department of Pathology St. Jude Children's Research Hospital Memphis Tennessee USA.
Background:
Expression of B-cell antigens is rare in T-lymphoblastic leukemia/lymphoma (T-LBLL), and the significance is uncertain.
Objective And Methods:
We present a pediatric case of acute leukemia characterized by the expression of T-cell markers and CD19, as determined by multicolor flow cytometry (MFC). Next-generation sequencing (NGS) revealed a SET::NUP214 gene fusion. The patient was treated with conventional intensive acute lymphoblastic leukemia (ALL) therapy. The end-of-induction evaluations showed significant residual disease.
Results:
While the patient failed high-risk T-LBLL induction therapy, blinatumomab followed by decitabine and venetoclax induced a morphologic remission. He then underwent a bone marrow stem cell transplant (BMSCT) and achieved a complete molecular remission.
Conclusions:
This case illustrated the importance of integrating MFC analysis with NGS data to provide individualized patient treatment.
Trial Registration:
The authors have confirmed clinical trial registration is not needed for this submission.
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
